A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorClinical Hospital Centre Zagreb
About this trial
The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures.
Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.
Eligibility criteria
Qualifiers
Patients both male and female
ages 18 to 60 years,
with one or more colonic polyps confirmed by colonoscopy and scheduled for a colonoscopy and polypectomy
The duration of the colonoscopy ranges from 30 to 50 minutes.
Disqualifiers
Patients aged >60 years
ASA status IV-V,
BMI >29.9 kg/m2,
a high risk of vomiting, regurgitation and/or aspiration of gastric contents.
Trial design
Treatments tested in this trial
- Remimazolam besylate
- Propofol
Treatment groups
90 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov